The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2
When Angelina Jolie announced last month that she decided to get a prophylactic double mastectomy, she based her decision on the presence of the BRCA1 gene in her body—a gene that was detected via a costly medical test.
The Supreme Court today unanimously struck down patents on BRCA1 and BRCA2—two genes linked to hereditary forms of breast and ovarian cancer—when the genes occur in the body. Myriad did not create or alter any of the genetic information of the BCRA1 and BRCA2 genes, and thus does not satisfy patenting requirements, according to the decision. “Myriad discovered the precise location and sequence of what are now known as the BRCA1 and BRCA2 genes,” Justice Clarence Thomas wrote for the court.
This ruling could lead to cheaper tests for individuals who may be at increased risk of developing cancer. If Myriad Genetics were allowed to hold exclusive patents on these genes, the company would have maintained sole rights to create medical tests that indicate whether an individual has mutations that would lead to elevated risk of developing these cancers.
The ruling should also affect the medical research community. Because the genes were patented, any researcher who found a new way to isolate the genes would not have been able to use it, since Myriad held patents on the genes themselves. The court’s decision removes that restriction.
On average, women have a 12 to 13 percent risk of developing breast cancer over their lifetimes, but that risk spikes with the presence of mutations in the BRCA1 andBRCA2 genes—jumping to between 50 and 80 percent for breast cancer and 20 and 50 percent for ovarian cancer, the decision notes.
Myriad had identified the exact location of the BRCA1 and BRCA2 genes; it had not discovered that heredity plays a role in establishing risk of breast and ovarian cancer. “Myriad did not create anything,” Thomas wrote. “To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention.” “I’m just incredibly relieved,” says Lisbeth Ceriani, a breast cancer survivor and original plaintiff who struggled to afford Myriad’s test.
The Latest Bing News on:
Gene patents
- Pfizer Gets FDA Approval For Rare Inherited Bleeding Disorder Gene Therapyon April 26, 2024 at 1:39 pm
In announcing its approval on Friday, the Food and Drug Administration said it had approved Pfizer’s treatment for a rare genetic bleeding disorder, making it the company’s first gene therapy to ...
- Meeting the cell and gene therapy scale-up challengeon April 25, 2024 at 9:00 am
One of the pivotal challenges in the development and commercialisation of cell and gene therapies (CGT) lies in scaling up production. This challenge is particularly pronounced as companies transition ...
- Gene Therapy For Ocular Rare Disease Pipeline Insight Report 2024on April 25, 2024 at 1:06 am
The "Gene Therapy For Ocular Rare Disease - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides comprehensive insights of present clinical ...
- HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECGon April 24, 2024 at 8:00 am
Today, measures of diastolic function of the heart need to be assessed in a specialist cardiology environment, typically using echocardiography-based imaging. The ability to assess cardiac diastolic ...
- AstraZeneca and Merck's Lynparza set to 'dominate' PARP marketon April 24, 2024 at 5:23 am
AstraZeneca and Merck & Co. were the first to grab an FDA approval for their PARP inhibitor Lynparza, and, despite growing competition, the drug is set to remain top dog in the PARP space. | ...
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- USDA Grants Amfora Exemption for Its Patented, Gene-Edited, Ultra-High Protein Soy, Accelerating Path to Marketon April 23, 2024 at 5:16 am
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) has granted Amfora, Inc. an exemption for its gene-edited, ultra-high protein soybeans. The exemption is a ...
- Iovance Biotherapeutics gets grant for gene-edited til composition with enhanced IFN secretionon April 22, 2024 at 5:20 am
Discover the groundbreaking patent by Iovance Biotherapeutics Inc for gene-edited TILs, enhancing efficacy and reducing costs in cancer immunotherapy.
- EXCLUSIVE: Alcohol Disorder Focused Adial Pharmaceuticals Secures US Patenton April 22, 2024 at 5:00 am
Adial Pharmaceuticals' genetic diagnostic patent, expanding treatment for alcohol and drug dependencies. CEO highlights the significance.
- European Parliament addresses thorny issue of plants generated by new genomic techniqueson April 16, 2024 at 7:00 am
Kerstin Wolff of Maiwald reports on a proposal that supports the use of some plants generated by new genomic techniques but opposes patents for all plants obtained by such means ...
The Latest Google Headlines on:
Gene patents
[google_news title=”” keyword=”gene patents” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Patent trolls
- All Galaxy smartphones affected: Samsung loses patent lawsuiton April 25, 2024 at 5:00 pm
Datang actively develops radio technology and products, so it is not just a so-called patent troll that lives off patent lawsuits. heise online has a redacted version of the judgment from April 12, ...
- Celebrating World IP Day: Is the Innovative Future Sustainable?on April 25, 2024 at 10:15 am
The World Intellectual Property Organization (WIPO) established World IP Day 19 years ago to celebrate the day on which the WIPO Convention entered into force: April 26, 1970. And this year, WIPO has ...
- Nicola Coughlan Claps Back at Hater Who Criticized Her for Wearing a Bra Top: ‘It Looked Good’on April 24, 2024 at 11:10 am
Nicola Coughlan defended a recent outfit she wore while doing a photoshoot with ‘Bridgerton’ costar Luke Newton ...
- Clearwater's KnowBe4 acquires UK cyber firm valued at more than $40 millionon April 24, 2024 at 10:09 am
Clearwater-based cybersecurity firm KnowBe4 will acquire tech firm Egress in the United Kingdom in the coming months.
- Moderna Investors Should Beware Patent-Dispute Fallouton April 23, 2024 at 11:40 am
Moderna's stock soared on positive cancer vaccine trial results, but legal troubles loom as a patent dispute threatens massive damages. Read my analysis here.
- Five practical ways to turbocharge competitionon April 18, 2024 at 4:42 pm
Former productivity commission chairman Peter Harris suggests that supermarkets, banks and qualifications are some of the areas to focus on.
- Manchin’s fight to protect W.Va. jobs must continueon April 16, 2024 at 6:21 pm
When Senator Joe Manchin discovered that a rogue federal agency could kill more than 900 jobs in West Virginia, he knew that he had to take action.
- How two small Texas towns became the patent-law centre of Americaon April 16, 2024 at 12:06 pm
Patent litigation could reasonably warrant a specialised court, similar to the system America uses to handle bankruptcy cases, stacked with experienced judges. “There are compelling reasons why ...
- KnowBe4 sued for patent infringement by 'patent troll'on April 16, 2024 at 4:12 am
The lawsuit alleges KnowBe4's offerings infringe on another patented technology. A South Florida-based IP attorney said it is not an easy case for the plaintiff.
- We need to pass U.S. Farm Bill, but we can't undermine it with harmful patent legislationon April 12, 2024 at 1:41 am
PERA, a paradigm-shifting piece of patent legislation, is quietly being considered in the halls of Congress, former U.S. Sen. Pat Roberts warns.
The Latest Google Headlines on:
Patent trolls
[google_news title=”” keyword=”fix the internet” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]